- Home
- AVIR vs RLGT Comparison
AVIR vs RLGT Comparison
Compare AVIR & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- RLGT
- Stock Information
- Founded
- AVIR 2012
- RLGT 2001
- Country
- AVIR United States
- RLGT United States
- Employees
- AVIR N/A
- RLGT N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- RLGT Oil Refining/Marketing
- Sector
- AVIR Health Care
- RLGT Consumer Discretionary
- Exchange
- AVIR Nasdaq
- RLGT Nasdaq
- Market Cap
- AVIR 273.7M
- RLGT 295.7M
- IPO Year
- AVIR 2020
- RLGT N/A
- Fundamental
- Price
- AVIR $2.55
- RLGT $6.41
- Analyst Decision
- AVIR Hold
- RLGT
- Analyst Count
- AVIR 1
- RLGT 0
- Target Price
- AVIR $6.00
- RLGT N/A
- AVG Volume (30 Days)
- AVIR 532.5K
- RLGT 113.6K
- Earning Date
- AVIR 05-12-2025
- RLGT 05-12-2025
- Dividend Yield
- AVIR N/A
- RLGT N/A
- EPS Growth
- AVIR N/A
- RLGT 187.49
- EPS
- AVIR N/A
- RLGT 0.35
- Revenue
- AVIR N/A
- RLGT $888,148,000.00
- Revenue This Year
- AVIR N/A
- RLGT $12.86
- Revenue Next Year
- AVIR N/A
- RLGT $5.26
- P/E Ratio
- AVIR N/A
- RLGT $18.30
- Revenue Growth
- AVIR N/A
- RLGT 7.18
- 52 Week Low
- AVIR $2.60
- RLGT $4.83
- 52 Week High
- AVIR $4.15
- RLGT $7.94
- Technical
- Relative Strength Index (RSI)
- AVIR 37.12
- RLGT 61.18
- Support Level
- AVIR $2.66
- RLGT $5.85
- Resistance Level
- AVIR $3.01
- RLGT $6.95
- Average True Range (ATR)
- AVIR 0.15
- RLGT 0.22
- MACD
- AVIR -0.03
- RLGT 0.08
- Stochastic Oscillator
- AVIR 7.02
- RLGT 56.45
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.